142 related articles for article (PubMed ID: 20156950)
1. Immunohistochemical analysis of osteoblasts in zygapophyseal joints of patients with ankylosing spondylitis reveal repair mechanisms similar to osteoarthritis.
Appel H; Maier R; Loddenkemper C; Kayser R; Meier O; Hempfing A; Sieper J
J Rheumatol; 2010 Apr; 37(4):823-8. PubMed ID: 20156950
[TBL] [Abstract][Full Text] [Related]
2. RANKL/OPG ratio and DKK-1 expression in primary osteoblastic cultures from osteoarthritic and osteoporotic subjects.
Corrado A; Neve A; Macchiarola A; Gaudio A; Marucci A; Cantatore FP
J Rheumatol; 2013 May; 40(5):684-94. PubMed ID: 23457386
[TBL] [Abstract][Full Text] [Related]
3. The ratio of messenger RNA levels of receptor activator of nuclear factor kappaB ligand to osteoprotegerin correlates with bone remodeling indices in normal human cancellous bone but not in osteoarthritis.
Fazzalari NL; Kuliwaba JS; Atkins GJ; Forwood MR; Findlay DM
J Bone Miner Res; 2001 Jun; 16(6):1015-27. PubMed ID: 11393778
[TBL] [Abstract][Full Text] [Related]
4. Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts.
Tat SK; Pelletier JP; Mineau F; Caron J; Martel-Pelletier J
Bone; 2011 Sep; 49(3):559-67. PubMed ID: 21700005
[TBL] [Abstract][Full Text] [Related]
5. The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation.
Vandooren B; Cantaert T; Noordenbos T; Tak PP; Baeten D
Arthritis Rheum; 2008 Mar; 58(3):718-29. PubMed ID: 18311801
[TBL] [Abstract][Full Text] [Related]
6. Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton.
Mountzios G; Dimopoulos MA; Bamias A; Papadopoulos G; Kastritis E; Syrigos K; Pavlakis G; Terpos E
Acta Oncol; 2007; 46(2):221-9. PubMed ID: 17453373
[TBL] [Abstract][Full Text] [Related]
7. Imbalance of the osteoprotegerin/RANKL ratio in bone marrow microenvironment after allogeneic hemopoietic stem cell transplantation.
Ricci P; Tauchmanova L; Risitano AM; Carella C; Mazziotti G; Lombardi G; Colao A; Rotoli B; Selleri C
Transplantation; 2006 Dec; 82(11):1449-56. PubMed ID: 17164716
[TBL] [Abstract][Full Text] [Related]
8. Histomorphologic and histomorphometric characteristics of zygapophyseal joint remodeling in ankylosing spondylitis.
Bleil J; Maier R; Hempfing A; Schlichting U; Appel H; Sieper J; Syrbe U
Arthritis Rheumatol; 2014 Jul; 66(7):1745-54. PubMed ID: 24574301
[TBL] [Abstract][Full Text] [Related]
9. In situ analysis of interleukin-6 expression at different sites of zygapophyseal joints from patients with ankylosing spondylitis in comparison to controls.
Bleil J; Maier R; Syrbe U; Sieper J; Appel H
Scand J Rheumatol; 2015; 44(4):296-301. PubMed ID: 25928402
[TBL] [Abstract][Full Text] [Related]
10. Nonsteroidal antiinflammatory drugs and prostaglandin E(2) modulate the synthesis of osteoprotegerin and RANKL in the cartilage of patients with severe knee osteoarthritis.
Moreno-Rubio J; Herrero-Beaumont G; Tardio L; Alvarez-Soria MA; Largo R
Arthritis Rheum; 2010 Feb; 62(2):478-88. PubMed ID: 20112374
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway.
Luo XH; Guo LJ; Xie H; Yuan LQ; Wu XP; Zhou HD; Liao EY
J Bone Miner Res; 2006 Oct; 21(10):1648-56. PubMed ID: 16995820
[TBL] [Abstract][Full Text] [Related]
12. Granulation Tissue Eroding the Subchondral Bone Also Promotes New Bone Formation in Ankylosing Spondylitis.
Bleil J; Maier R; Hempfing A; Sieper J; Appel H; Syrbe U
Arthritis Rheumatol; 2016 Oct; 68(10):2456-65. PubMed ID: 27111225
[TBL] [Abstract][Full Text] [Related]
13. Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity.
Irie A; Takami M; Kubo H; Sekino-Suzuki N; Kasahara K; Sanai Y
Bone; 2007 Aug; 41(2):165-74. PubMed ID: 17560185
[TBL] [Abstract][Full Text] [Related]
14. Prolactin directly enhances bone turnover by raising osteoblast-expressed receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio.
Seriwatanachai D; Thongchote K; Charoenphandhu N; Pandaranandaka J; Tudpor K; Teerapornpuntakit J; Suthiphongchai T; Krishnamra N
Bone; 2008 Mar; 42(3):535-46. PubMed ID: 18166509
[TBL] [Abstract][Full Text] [Related]
15. Metabolic activity of osteoblasts from periprosthetic trabecular bone in failed total hip arthroplasties and osteoarthritis as markers of osteolysis and loosening.
Shi Q; Lajeunesse D; Reboul P; Martel-Pelletier J; Pelletier JP; Dehnade F; Fernandes JC
J Rheumatol; 2002 Jul; 29(7):1437-45. PubMed ID: 12136903
[TBL] [Abstract][Full Text] [Related]
16. Long chain polyunsaturated fatty acids alter membrane-bound RANK-L expression and osteoprotegerin secretion by MC3T3-E1 osteoblast-like cells.
Poulsen RC; Wolber FM; Moughan PJ; Kruger MC
Prostaglandins Other Lipid Mediat; 2008 Feb; 85(1-2):42-8. PubMed ID: 18077200
[TBL] [Abstract][Full Text] [Related]
17. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro: possible role in subchondral bone sclerosis.
Hilal G; Martel-Pelletier J; Pelletier JP; Ranger P; Lajeunesse D
Arthritis Rheum; 1998 May; 41(5):891-9. PubMed ID: 9588742
[TBL] [Abstract][Full Text] [Related]
18. Differential bone metabolism between postmenopausal women with osteoarthritis and osteoporosis.
Jiang LS; Zhang ZM; Jiang SD; Chen WH; Dai LY
J Bone Miner Res; 2008 Apr; 23(4):475-83. PubMed ID: 18052758
[TBL] [Abstract][Full Text] [Related]
19. Expression of RANKL and OPG correlates with age-related bone loss in male C57BL/6 mice.
Cao J; Venton L; Sakata T; Halloran BP
J Bone Miner Res; 2003 Feb; 18(2):270-7. PubMed ID: 12568404
[TBL] [Abstract][Full Text] [Related]
20. Alendronate and raloxifene affect the osteoprotegerin/RANKL system in human osteoblast primary cultures from patients with osteoporosis and osteoarthritis.
Giner M; Rios MJ; Montoya MJ; Vázquez MA; Miranda C; Pérez-Cano R
Eur J Pharmacol; 2011 Jan; 650(2-3):682-7. PubMed ID: 21050847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
